Lavo Life Sciences

Lavo delivers AI‑powered crystal structure prediction for drug molecules, enabling faster and safer formulation optimization.

Pricing Model: Paid

Category: Business Automation & Management Ai Tools

https://lavo.ai/

Release Date: 25/05/2023

• Predicts crystal structures of small‑molecule drug candidates using advanced AI models
• Enables virtual polymorph screening to explore alternate crystalline forms
• Analyzes solid‑state formulation risk by comparing predicted structures and experimental data
• Provides interactive 3D visualization of crystal packing and polymorph landscapes
• Accepts PXRD (powder X‑ray diffraction) data uploads for automated comparison with predicted structures
• Helps optimize formulation stability and manufacturability by identifying favourable polymorphs
• Offers contract research services for custom investigations alongside a self‑service platform
• Deep domain expertise combining computational chemistry and machine learning workflows
• Cloud‑based infrastructure for high‑throughput predictions at pharma‑scale
• Helps reduce development timeline and cost by mitigating late‑stage crystal form surprises

Lavo Life Sciences is an AI‑first platform designed for pharmaceutical development teams who need accurate, early‑stage prediction of drug crystal structures. By leveraging proprietary machine learning models and computational chemistry algorithms, Lavo enables virtual screening of molecular packing, identification of alternative polymorphs and assessment of formulation risks long before physical experiments dominate the timeline. The platform helps research teams upload molecular candidates or PXRD data, explore three‑dimensional crystal landscapes interactively, and derive actionable insights on solid‑state stability, manufacturability and export‑ready formulation. With its focus on accelerating drug development pipelines, Lavo supports both a self‑service web‑based interface and bespoke contract research services for deeper custom studies. The ability to predict crystal structures and compare them to experimental diffraction data reduces the typical time‑to‑insight in formulation development by orders of magnitude. For organizations seeking to de‑risk late‑stage surprises—such as unexpected polymorph transitions or manufacturing issues—the platform offers a unique combination of AI speed and domain‑specific scientific rigour. In essence, Lavo helps pharmaceutical teams move from molecule to manufacturable solid‑state form more efficiently, enabling earlier decision‑making, cost savings and a higher probability of successful drug development.

Alternative to Lavo Life Sciences